Alliance Pharma to acquire Cambridge Labs

Specialty pharmaceutical company Alliance Pharma plc (LSE:APH) plans to acquire Cambridge Laboratories Ltd. (Dublin, Ireland) for up to L14.3 million ($22.3 million) in cash plus potential milestones of up to L2.1 million ($3.3 million). Alliance gains 18 marketed prescription products, including ImmuCyst to treat and prevent non-muscle invasive bladder cancer. Cambridge Labs had 2009 sales of L10.6 million ($16.6 million). The deal is expected to close on Feb. 22. ...